Anti-CD52 Antibody (Alemtuzumab)
Catalog No.
F1073
Anti-CD52 Antibody (Alemtuzumab)
Featured Products
Alemtuzumab (Campath-IH) is a humanized monoclonal antibody against CD52 that does not cross-react with murine CD52. Alemtuzumab selectively targets the CD52 antigen, inducing profound lymphocyte depletion and then restoring T and B cells with a regulatory phenotype. Alemtuzumab is able to produce complement-dependent cytotoxicity and antibody-dependent cell-mediated cytotoxicity (ADCC), as well as induce apoptosis. Alemtuzumab has the potential to be used in the study of B-cell chronic lymphocytic leukemia.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146.06 kDa
Dry ice
216503-57-0
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Campath, MabCampath, Lemtrada
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P31358
Human, Mouse, Rat
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
CD52
Please avoid freeze-thaw cycles.